Kaya Miah

Kaya Miah

Kaya Miah

Position:

Scientist

Phone:

+49 6221 422133

Fax:

+49 6221 42 2397

Building:

TP 4

Room:

S4.220

Research Interests

  • Survival analysis
  • Clinical trials
  • Competing risks

Education and Background

  • DKFZ / Biostatistics since September 2019
  • Semester abroad at School of Mathematics and Statistics, University of Sheffield, England (2017-2018)
  • M.Sc. in Statistics with focus on Biometrics, Dortmund University (2016-2019)
  • B.Sc. in Statistics/Theoretical Medicine, Dortmund University (2013-2016)

Publications

Mai, E. K., Miah, K., Bertsch, U., Dürig, J., Scheid, C., Weisel, K. C., Kunz, C., Munder, M., Lindemann, H. W., Merz, M., Hose, D., Jauch, A., Seckinger, A., Luntz, S., Sauer, S., Fuhrmann, S., Brossart, P., Elmaagacli, A., Goerner, M., Bernhard, H., Hoffmann, M., Raab, M. S., Blau, I. W., Hänel, M., Benner, A., Salwender, H. J. and Goldschmidt, H. German-speaking Myeloma Multicenter Group (GMMG) (2020). Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age. Leukemia.

to top
powered by webEdition CMS